Inhibition of Alternative Cancer Cell Metabolism of EGFR Mutated Non-Small Cell Lung Cancer Serves as a Potential Therapeutic Strategy

Targeted therapy is an efficient treatment for patients with epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC). Therapeutic resistance invariably occurs in NSCLC patients. Many studies have focused on drug resistance mechanisms, but only a few have addressed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chung-Yu, Hsu, Li-Han, Chen, Chung-Yeh, Chang, Gee-Chen, Chang, Hui-Wen, Hung, Yi-Mei, Liu, Ko-Jiunn, Kao, Shu-Huei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017237/
https://www.ncbi.nlm.nih.gov/pubmed/31936895
http://dx.doi.org/10.3390/cancers12010181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017237/
https://www.ncbi.nlm.nih.gov/pubmed/31936895
http://dx.doi.org/10.3390/cancers12010181

Ejemplares similares